バイオリアクター市場：メカニズム、用途、制御タイプ、材料、規模、使用性、エンドユーザー別-2024～2030年の世界予測

バイオリアクター市場規模は、2023年に32億6,000万米ドルと推定され、2024年には35億7,000万米ドルに達し、CAGR 9.46％で2030年には61億5,000万米ドルに達すると予測されています。

バイオリアクターは、医薬品、飲食品、バイオテクノロジー研究施設、廃水処理プラントなど様々な産業において、生物学的プロセスに制御された環境を提供する特殊容器の設計、製造、使用、保守を含みます。個別化医薬品や治療用抗体に対する需要の増加、機能面での技術進歩、ワクチン製造拡大のための政府機関や民間セクターからの投資の増加が、市場成長の原動力となっています。製薬施設や廃棄物処理施設でのシングルユースバイオリアクターの使用増加により、市場規模が拡大しています。しかし、バイオリアクターの大量使用に伴う安全性やメンテナンスの問題が、市場成長の妨げになると予想されます。バイオ医薬品事業者が業務の効率と精度を改善できるような先進的なバイオリアクターを導入するための研究開発活動が活発化していることが、市場成長の機会を生み出すと予想されます。現在進行中のバイオリアクターの進歩は、再生医療応用のための標準化された反復可能な細胞ベースの製品を開発し、薬剤試験のための生理学的に現実的なin vitroモデルを確立することが期待されます。

メカニズム光合成微生物の増殖のための光バイオリアクターの採用

エアリフトバイオリアクターは、好気性発酵や細胞培養を含む、低剪断ストレスプロセスや高酸素移動アプリケーションに最適です。ベンチトップ型バイオリアクターは、小規模実験やプロセス開発用に設計されており、研究所や研究機関で人気があります。バブルカラムバイオリアクターは、混合と物質移動にガス・スパージングを利用し、シンプルな設計と低い運転コストにより、大規模生産に適しています。連続攪拌タンク（CSTR）は、均一な液相反応に柔軟なプロセス制御を記載しています。流動床バイオリアクターは、固定化された細胞や微生物を液体培地に懸濁させる高密度細胞培養プロセスに優れています。微生物バイオリアクターは、タンパク質生産、酵素合成、廃棄物処理用途の微生物培養に特化しています。マルチパラレルバイオリアクターでは、制御された条件下で複数のリアクターによる同時実験が可能です。これらのリアクターは、プロセスの最適化、ハイスループット・スクリーニング、スケールアップ研究に適しています。パックドベッドバイオリアクターは、多孔質マトリックス内に固定化された細胞や粒子を含み、細胞密度の高い培養と細胞付着のための広い表面積を記載しています。このリアクターは、バイオフィルムベースのプロセスや廃水処理などの用途に利用されています。Photo-バイオリアクターは、光合成微生物の増殖に不可欠な光条件を制御し、最適な培養環境を記載しています。

用途：大量処理が可能なため、各業界から本格生産が好まれる

フルスケール生産は、容積容量と操作の複雑さに関して、バイオリアクターの使用タイプの最高レベルに相当します。これらの大容量システムは、1,000リットルから20,000リットルを超え、医薬品、バイオテクノロジー、食品加工、農業、環境管理など様々な産業で利用されています。本格的なバイオリアクターでは、大量の細胞や微生物を制御された条件下で培養し、組換えタンパク質や酵素など、様々な用途に適した製品を生産します。このセグメントでは、効率的な資源利用で製品の品質と一貫性を維持しながら、高収率で生産することに主眼が置かれています。ラボスケール生産とは、主に学術機関や産業研究開発センターでの研究に使用される、作業容量が1リットルから10リットルの小型のものを指します。そのコンパクトなサイズは、pH制御や温度調節など、より大規模なシステムと同様の本質的な機能を提供しながら、実験室環境内での取り扱いと操作を容易にします。研究者は、より大規模なパイロット・スケールやフル・スケールのシステムにプロセスを移行する前に、小規模なスケールで細胞培養の最適化研究や培地スクリーニング試験など、ラボ・スケールの生産環境で様々な実験手順を実施することができ、時間とリソースを節約することができます。パイロット・スケール生産は、ラボ・スケール生産とフル・スケール生産の中間段階であり、ベンチトップ・スケールで開発されたプロセスを、約100～数千リットルの大容量に対応するようにスケールアップします。この段階は、小規模な実験室での研究と商業規模の製造とのギャップを埋めるものであるため、バイオプロセスのパラメーターを評価し最適化する上で極めて重要です。パイロット・スケールのバイオリアクターでは、物質移動速度、混合パターン、栄養供給などの様々な要因をより現実的な条件下で研究することができ、プロセスの頑健性、拡大性、経済的実現可能性に関する貴重なデータが得られます。また、パイロット施設は、プロセスのバリデーション、技術移転活動、規制遵守試験のための不可欠なプラットフォームとしても機能します。

制御タイプ：プロセス制御の精度と一貫性の高さによる自動バイオリアクターの採用

自動バイオリアクターは、pH、温度、溶存酸素、撹拌速度などの重要なプロセスパラメーターを制御・監視する高度なシステムです。これらのバイオリアクターは、高精度で一貫性のあるプロセスコントロールを提供し、製品の品質向上とバッチのばらつきを低減します。自動化されたバイオリアクターは、継続的なモニタリングと正確なコントロールが最適なパフォーマンスを実現するために不可欠な、大規模な工業生産プロセスに適しています。手動バイオリアクターは、細胞培養や発酵プロセスにおいて、オペレーターが手動でプロセスパラメーターを調整する必要があります。これらのシステムは、特定の要件に基づいて条件を変更する柔軟性をユーザーに提供し、実験条件を最適化するために頻繁な調整が必要な小規模の研究室で使用されます。

材料：耐久性と拡大性により、製薬・バイオ産業でステンレス鋼バイオリアクターの使用が増加しています。

バイオリアクターは、バイオプロセス・アプリケーションに不可欠なコンポーネントであり、一般的にガラスまたはステンレス鋼で作られています。ガラス製のバイオリアクターは、透明性と耐薬品性に優れ、培養の成長、細胞の形態、最大15Lまでのプロセスを観察することができます。一方、ステンレス製のバイオリアクターは、耐久性、拡大性に優れており、特に製薬・バイオ産業における20Lから1,000L以上の大規模製造プロセスに最適です。各バイオリアクターは、特定のアプリケーション要件に応じて明確な利点があります。エンドユーザーは、メーカー/プロバイダーと相談し、ニーズに最も適したモデルを決定することが推奨されます。

規模：200～1500Lのパイロットスケールと小規模商業生産プロセスへの適合性バイオリアクター

1500～4,000Lのスケールは、商業生産のために高い処理能力と生産量の増加を必要とする大規模生産施設に対応します。モノクローナル抗体、ワクチン、組換えタンパク質の製造に適しています。200～1500Lのバイオリアクターは、パイロットスケールや小規模の商業生産プロセスに適しており、ベンチトップシステムからの効率的なスケールアップが可能です。これらのバイオリアクターは、哺乳類または微生物細胞を含む細胞培養プロセスによく使用されます。20～200Lのバイオリアクターは、実験室やパイロットスケールでのプロセス開発や最適化のニーズに対応します。このレンジは、効果的なスケールダウン機能を提供し、より大規模なシステムに最適なプロセス条件を可能にします。5～20Lバイオリアクターは、研究開発、初期スクリーニング、培地の最適化に適しています。5～20Lのベンチトップ型バイオリアクターは、取り扱いが簡単で、必要なスペースが少なくて済みます。4,000L以上のバイオリアクターは、大容量の生産設備を必要とする大規模な商業生産に適しています。これらのシステムは、大規模なバイオ治療の製造や大量発酵プロセスに一般的に採用されています。

使用性：柔軟性があり、交差汚染のリスクが少ないシングルユースのバイオリアクターが好まれます。

再利用可能なバイオリアクターは、ステンレスやガラスなどの耐久性のある材料から作られており、適切な洗浄と滅菌の後、何度も使用することができます。細胞密度が高く、大容量に対応できるため、大規模な製造工程に広く採用されています。シングルユースバイオリアクターは、プラスチックやポリマーを含む材料で作られた使い捨てのコンポーネントを採用し、使用ごとに廃棄されます。これらのシステムは、その柔軟性、二次汚染のリスクの低減、生産稼働のための迅速なターンアラウンド・タイムにより、広く普及しています。

エンドユーザー：モノクローナル抗体やワクチンを含むバイオ医薬品の製造に、バイオ医薬品産業での適用が増加しています。

バイオリアクターは、モノクローナル抗体、ワクチン、組み換えタンパク質、細胞治療製品などのバイオ医薬品を製造するバイオ医薬品業界で重要な役割を果たしています。これらの企業は、バイオ製造を通して無菌性を維持しながら、細胞増殖とタンパク質発現に最適な条件を提供するバイオリアクターに依存しています。実験室から大規模な商業生産までスケールアップできるバイオリアクターは、バイオ医薬品に欠かせない存在です。CMOやCROは、医薬品開発や製造に関する専門的なサービスを契約ベースで提供しています。CMOやCROは、バイオリアクターをプロセス開発、最適化研究、スケールアップ活動、臨床試験材料製造、治療の商業生産など様々な用途に活用しています。バイオリアクターは、嫌気性消化やバイオガス生産プロセスのための埋立地や廃棄物処理プラントなどの廃棄物管理産業にも採用されています。これらのシステムは、微生物を利用して有機物を分解し、メタンガスからエネルギーを生成し、温室効果ガスの排出を削減します。バイオリアクターの効率的な設計と運用は、これらのプロセスの全体的な有効性を決定する上で極めて重要な役割を果たします。バイオリアクターは、細胞培養、発酵プロセス、生化学工学の研究、バイオベースの新製品や代替エネルギー源の開発など、さまざまな研究活動において、研究機関や学術機関から高い信頼を得ています。バイオリアクターは、pHレベルや栄養素の利用可能性などの異なる成長条件下で細胞の反応を調査するための制御された環境を提供し、研究者がプロセスパラメータを最適化したり、新しい生物学的経路を調査することを可能にします。

地域別洞察

南北アメリカ、特に北米では、交差汚染のリスクを低減できることから、シングルユースまたはディスポーザブルのバイオリアクターの需要が増加しています。ライフサイエンス産業が高度に発展し、官民双方からの資金調達が活発化していることが、南北アメリカにおけるバイオリアクター市場成長の基盤となっています。医薬品製造能力の拡大、急速な工業化により、ワクチン、バイオシミラー、幹細胞療法に必要な生産能力が高まり、アジア太平洋でのバイオリアクターの利用が増加しています。さらに、研究開発投資を促進する政府のイニシアチブと有利な規制政策が、アジア太平洋の市場成長に利益をもたらすと期待されています。欧州、中東、アフリカでは、欧州が世界のバイオリアクター市場の中で支配的な地位を占めており、ドイツ、フランス、英国などが地域の成長をリードしています。この背景には、強固な製品パイプラインを持つ老舗製薬会社、政府の支援政策、学術機関と市場関係者の協力関係の増加、バイオプロセス革新の重視などがあります。一方、中東・アフリカでは、サウジアラビアや南アフリカなどの国々がバイオファーマのインフラ整備と生産能力拡大に投資を続けており、徐々にバイオファーマが浸透しつつあります。

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスはバイオリアクター市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を記載しています。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます。フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、バイオリアクター市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、このセグメントの競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています。

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を記載しています。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発とイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を記載しています。

本レポートは、以下のような主要な質問に対応しています。

1.バイオリアクター市場の市場規模と予測は？

2.バイオリアクター市場の予測期間中に投資を検討すべき製品、用途は何か？

3.バイオリアクター市場の技術動向と規制枠組みは？

4.バイオリアクター市場における主要ベンダーの市場シェアは？

5.バイオリアクター市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • バイオ医薬品と生物製剤産業の急速な成長
    • 単発バイオリアクター（サブ）とハイブリッドバイオリアクターの採用
  • 抑制要因
    • バイオリアクターのメンテナンスの問題と高電力消費の問題
  • 機会
    • 新しいバイオリアクターの開発における継続的な技術進歩
    • 廃水処理プロセスにおけるバイオリアクターの高い可能性
  • 課題
    • バイオリアクターの使用に関連する安全性と環境に関する懸念
• 市場セグメンテーション分析
  • メカニズム：光合成微生物の増殖のための光バイオリアクターの採用
  • 用途：大量処理能力により、さまざまな業界の本格的な生産に適しています
  • 制御タイプ：プロセス制御における高い精度と一貫性のため、自動化されたバイオリアクターを採用
  • 材料：耐久性と拡大性により、製薬業界とバイオテクノロジー業界でステンレス鋼の使用が増加しています。
  • 規模：パイロットスケールと小規模商業製造プロセスにおける200L～1,500Lのバイオリアクターの適合性
  • 使用性：柔軟性と交差汚染のリスクの低減のため、使い捨てのバイオリアクターが好まれる
  • エンドユーザー：モノクローナル抗体やワクチンなどのバイオ医薬品の製造におけるバイオ医薬品業界での適用範囲が拡大
• 市場動向分析
  • 南北アメリカの確立された生産施設のサポートにより、先進的なバイオリアクターの研究開発活動に重点を置く
  • 医薬品製造における政府の支援策と技術導入の強化
  • 活発なバイオ医薬品調査活動と地域における確固たる地位を築いた企業
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制枠組みの分析

第6章 バイオリアクター市場：メカニズム別

• イントロダクション
• 空輸バイオリアクター
• ベンチトップバイオリアクター
• バブルコラムバイオリアクター
• 連続撹拌タンクバイオリアクター
• 流動床バイオリアクター
• 微生物バイオリアクター
• マルチパラレルバイオリアクター
• 詰め込まれたベッドバイオリアクター
• 光バイオリアクター

第7章 バイオリアクター市場：用途別

• イントロダクション
• 本格生産
• ラボ規模の生産
• パイロット規模の生産

第8章 バイオリアクター市場：制御タイプ別

• イントロダクション
• 自動
• 手動

第9章 バイオリアクター市場：材料別

• イントロダクション
• ガラス
• ステンレス鋼

第10章 バイオリアクター市場：規模別

• イントロダクション
• 1500～4,000L
• 200～1500L
• 20～200L
• 5～20L
• 4,000L以上

第11章 バイオリアクター市場：使用性別

• イントロダクション
• 再利用可能
• 使い捨て

第12章 バイオリアクター市場：エンドユーザー別

• イントロダクション
• バイオ医薬品企業と製造業者
• 契約製造組織と契約調査組織
• 埋立地と廃棄物処理施設
• 研究開発部門と研究所

第13章 南北アメリカのバイオリアクター市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第14章 アジア太平洋のバイオリアクター市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第15章 欧州・中東・アフリカのバイオリアクター市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第16章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析

第17章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. BIOREACTORS MARKET RESEARCH PROCESS
• FIGURE 2. BIOREACTORS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BIOREACTORS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BIOREACTORS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL BIOREACTORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. BIOREACTORS MARKET DYNAMICS
• FIGURE 7. GLOBAL BIOREACTORS MARKET SIZE, BY MECHANISM, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL BIOREACTORS MARKET SIZE, BY MECHANISM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL BIOREACTORS MARKET SIZE, BY USAGE, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL BIOREACTORS MARKET SIZE, BY USAGE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL BIOREACTORS MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL BIOREACTORS MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. GLOBAL BIOREACTORS MARKET SIZE, BY SCALE, 2023 VS 2030 (%)
• FIGURE 16. GLOBAL BIOREACTORS MARKET SIZE, BY SCALE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. GLOBAL BIOREACTORS MARKET SIZE, BY USABILITY, 2023 VS 2030 (%)
• FIGURE 18. GLOBAL BIOREACTORS MARKET SIZE, BY USABILITY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. GLOBAL BIOREACTORS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 20. GLOBAL BIOREACTORS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. AMERICAS BIOREACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. AMERICAS BIOREACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. UNITED STATES BIOREACTORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 24. UNITED STATES BIOREACTORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 25. ASIA-PACIFIC BIOREACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 26. ASIA-PACIFIC BIOREACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 27. EUROPE, MIDDLE EAST & AFRICA BIOREACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 28. EUROPE, MIDDLE EAST & AFRICA BIOREACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 29. BIOREACTORS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 30. BIOREACTORS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BIOREACTORS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BIOREACTORS MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL BIOREACTORS MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL BIOREACTORS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL BIOREACTORS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL BIOREACTORS MARKET SIZE, BY MECHANISM, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL BIOREACTORS MARKET SIZE, BY AIRLIFT BIOREACTORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL BIOREACTORS MARKET SIZE, BY AIRLIFT BIOREACTORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL BIOREACTORS MARKET SIZE, BY BENCHTOP BIOREACTORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL BIOREACTORS MARKET SIZE, BY BENCHTOP BIOREACTORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL BIOREACTORS MARKET SIZE, BY BUBBLE COLUMN BIOREACTORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL BIOREACTORS MARKET SIZE, BY BUBBLE COLUMN BIOREACTORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL BIOREACTORS MARKET SIZE, BY CONTINUOUS STIRRED TANK BIOREACTORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL BIOREACTORS MARKET SIZE, BY CONTINUOUS STIRRED TANK BIOREACTORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL BIOREACTORS MARKET SIZE, BY FLUIDIZED BED BIOREACTORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL BIOREACTORS MARKET SIZE, BY FLUIDIZED BED BIOREACTORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL BIOREACTORS MARKET SIZE, BY MICROBIAL BIOREACTORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL BIOREACTORS MARKET SIZE, BY MICROBIAL BIOREACTORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL BIOREACTORS MARKET SIZE, BY MULTI-PARALLEL BIOREACTORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL BIOREACTORS MARKET SIZE, BY MULTI-PARALLEL BIOREACTORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL BIOREACTORS MARKET SIZE, BY PACKED BED BIOREACTORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL BIOREACTORS MARKET SIZE, BY PACKED BED BIOREACTORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL BIOREACTORS MARKET SIZE, BY PHOTO-BIOREACTORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL BIOREACTORS MARKET SIZE, BY PHOTO-BIOREACTORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL BIOREACTORS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL BIOREACTORS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL BIOREACTORS MARKET SIZE, BY FULL-SCALE PRODUCTION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL BIOREACTORS MARKET SIZE, BY FULL-SCALE PRODUCTION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL BIOREACTORS MARKET SIZE, BY LAB-SCALE PRODUCTION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL BIOREACTORS MARKET SIZE, BY LAB-SCALE PRODUCTION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL BIOREACTORS MARKET SIZE, BY PILOT-SCALE PRODUCTION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL BIOREACTORS MARKET SIZE, BY PILOT-SCALE PRODUCTION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL BIOREACTORS MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL BIOREACTORS MARKET SIZE, BY AUTOMATED, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL BIOREACTORS MARKET SIZE, BY MANUAL, BY REGION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL BIOREACTORS MARKET SIZE, BY MANUAL, BY REGION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL BIOREACTORS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL BIOREACTORS MARKET SIZE, BY GLASS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL BIOREACTORS MARKET SIZE, BY GLASS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL BIOREACTORS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL BIOREACTORS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2024-2030 (USD MILLION)
• TABLE 47. GLOBAL BIOREACTORS MARKET SIZE, BY SCALE, 2018-2023 (USD MILLION)
• TABLE 48. GLOBAL BIOREACTORS MARKET SIZE, BY SCALE, 2024-2030 (USD MILLION)
• TABLE 49. GLOBAL BIOREACTORS MARKET SIZE, BY 1500L-4000L, BY REGION, 2018-2023 (USD MILLION)
• TABLE 50. GLOBAL BIOREACTORS MARKET SIZE, BY 1500L-4000L, BY REGION, 2024-2030 (USD MILLION)
• TABLE 51. GLOBAL BIOREACTORS MARKET SIZE, BY 200L-1500L, BY REGION, 2018-2023 (USD MILLION)
• TABLE 52. GLOBAL BIOREACTORS MARKET SIZE, BY 200L-1500L, BY REGION, 2024-2030 (USD MILLION)
• TABLE 53. GLOBAL BIOREACTORS MARKET SIZE, BY 20L-200L, BY REGION, 2018-2023 (USD MILLION)
• TABLE 54. GLOBAL BIOREACTORS MARKET SIZE, BY 20L-200L, BY REGION, 2024-2030 (USD MILLION)
• TABLE 55. GLOBAL BIOREACTORS MARKET SIZE, BY 5L-20L, BY REGION, 2018-2023 (USD MILLION)
• TABLE 56. GLOBAL BIOREACTORS MARKET SIZE, BY 5L-20L, BY REGION, 2024-2030 (USD MILLION)
• TABLE 57. GLOBAL BIOREACTORS MARKET SIZE, BY ABOVE 4000L, BY REGION, 2018-2023 (USD MILLION)
• TABLE 58. GLOBAL BIOREACTORS MARKET SIZE, BY ABOVE 4000L, BY REGION, 2024-2030 (USD MILLION)
• TABLE 59. GLOBAL BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
• TABLE 60. GLOBAL BIOREACTORS MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
• TABLE 61. GLOBAL BIOREACTORS MARKET SIZE, BY REUSABLE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 62. GLOBAL BIOREACTORS MARKET SIZE, BY REUSABLE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 63. GLOBAL BIOREACTORS MARKET SIZE, BY SINGLE-USE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 64. GLOBAL BIOREACTORS MARKET SIZE, BY SINGLE-USE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 65. GLOBAL BIOREACTORS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 66. GLOBAL BIOREACTORS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 67. GLOBAL BIOREACTORS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES & MANUFACTURERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 68. GLOBAL BIOREACTORS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES & MANUFACTURERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 69. GLOBAL BIOREACTORS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS & CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 70. GLOBAL BIOREACTORS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS & CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 71. GLOBAL BIOREACTORS MARKET SIZE, BY LANDFILLS & WASTE TREATMENT PLANTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 72. GLOBAL BIOREACTORS MARKET SIZE, BY LANDFILLS & WASTE TREATMENT PLANTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 73. GLOBAL BIOREACTORS MARKET SIZE, BY R&D DEPARTMENTS & INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 74. GLOBAL BIOREACTORS MARKET SIZE, BY R&D DEPARTMENTS & INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 75. AMERICAS BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2023 (USD MILLION)
• TABLE 76. AMERICAS BIOREACTORS MARKET SIZE, BY MECHANISM, 2024-2030 (USD MILLION)
• TABLE 77. AMERICAS BIOREACTORS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
• TABLE 78. AMERICAS BIOREACTORS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
• TABLE 79. AMERICAS BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2023 (USD MILLION)
• TABLE 80. AMERICAS BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2024-2030 (USD MILLION)
• TABLE 81. AMERICAS BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
• TABLE 82. AMERICAS BIOREACTORS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
• TABLE 83. AMERICAS BIOREACTORS MARKET SIZE, BY SCALE, 2018-2023 (USD MILLION)
• TABLE 84. AMERICAS BIOREACTORS MARKET SIZE, BY SCALE, 2024-2030 (USD MILLION)
• TABLE 85. AMERICAS BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
• TABLE 86. AMERICAS BIOREACTORS MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
• TABLE 87. AMERICAS BIOREACTORS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 88. AMERICAS BIOREACTORS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 89. AMERICAS BIOREACTORS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 90. AMERICAS BIOREACTORS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 91. ARGENTINA BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2023 (USD MILLION)
• TABLE 92. ARGENTINA BIOREACTORS MARKET SIZE, BY MECHANISM, 2024-2030 (USD MILLION)
• TABLE 93. ARGENTINA BIOREACTORS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
• TABLE 94. ARGENTINA BIOREACTORS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
• TABLE 95. ARGENTINA BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2023 (USD MILLION)
• TABLE 96. ARGENTINA BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2024-2030 (USD MILLION)
• TABLE 97. ARGENTINA BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
• TABLE 98. ARGENTINA BIOREACTORS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
• TABLE 99. ARGENTINA BIOREACTORS MARKET SIZE, BY SCALE, 2018-2023 (USD MILLION)
• TABLE 100. ARGENTINA BIOREACTORS MARKET SIZE, BY SCALE, 2024-2030 (USD MILLION)
• TABLE 101. ARGENTINA BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
• TABLE 102. ARGENTINA BIOREACTORS MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
• TABLE 103. ARGENTINA BIOREACTORS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 104. ARGENTINA BIOREACTORS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 105. BRAZIL BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2023 (USD MILLION)
• TABLE 106. BRAZIL BIOREACTORS MARKET SIZE, BY MECHANISM, 2024-2030 (USD MILLION)
• TABLE 107. BRAZIL BIOREACTORS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
• TABLE 108. BRAZIL BIOREACTORS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
• TABLE 109. BRAZIL BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2023 (USD MILLION)
• TABLE 110. BRAZIL BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2024-2030 (USD MILLION)
• TABLE 111. BRAZIL BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
• TABLE 112. BRAZIL BIOREACTORS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
• TABLE 113. BRAZIL BIOREACTORS MARKET SIZE, BY SCALE, 2018-2023 (USD MILLION)
• TABLE 114. BRAZIL BIOREACTORS MARKET SIZE, BY SCALE, 2024-2030 (USD MILLION)
• TABLE 115. BRAZIL BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
• TABLE 116. BRAZIL BIOREACTORS MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
• TABLE 117. BRAZIL BIOREACTORS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 118. BRAZIL BIOREACTORS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 119. CANADA BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2023 (USD MILLION)
• TABLE 120. CANADA BIOREACTORS MARKET SIZE, BY MECHANISM, 2024-2030 (USD MILLION)
• TABLE 121. CANADA BIOREACTORS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
• TABLE 122. CANADA BIOREACTORS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
• TABLE 123. CANADA BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2023 (USD MILLION)
• TABLE 124. CANADA BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2024-2030 (USD MILLION)
• TABLE 125. CANADA BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
• TABLE 126. CANADA BIOREACTORS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
• TABLE 127. CANADA BIOREACTORS MARKET SIZE, BY SCALE, 2018-2023 (USD MILLION)
• TABLE 128. CANADA BIOREACTORS MARKET SIZE, BY SCALE, 2024-2030 (USD MILLION)
• TABLE 129. CANADA BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
• TABLE 130. CANADA BIOREACTORS MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
• TABLE 131. CANADA BIOREACTORS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 132. CANADA BIOREACTORS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 133. MEXICO BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2023 (USD MILLION)
• TABLE 134. MEXICO BIOREACTORS MARKET SIZE, BY MECHANISM, 2024-2030 (USD MILLION)
• TABLE 135. MEXICO BIOREACTORS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
• TABLE 136. MEXICO BIOREACTORS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
• TABLE 137. MEXICO BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2023 (USD MILLION)
• TABLE 138. MEXICO BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2024-2030 (USD MILLION)
• TABLE 139. MEXICO BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
• TABLE 140. MEXICO BIOREACTORS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
• TABLE 141. MEXICO BIOREACTORS MARKET SIZE, BY SCALE, 2018-2023 (USD MILLION)
• TABLE 142. MEXICO BIOREACTORS MARKET SIZE, BY SCALE, 2024-2030 (USD MILLION)
• TABLE 143. MEXICO BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
• TABLE 144. MEXICO BIOREACTORS MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
• TABLE 145. MEXICO BIOREACTORS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 146. MEXICO BIOREACTORS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 147. UNITED STATES BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2023 (USD MILLION)
• TABLE 148. UNITED STATES BIOREACTORS MARKET SIZE, BY MECHANISM, 2024-2030 (USD MILLION)
• TABLE 149. UNITED STATES BIOREACTORS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
• TABLE 150. UNITED STATES BIOREACTORS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
• TABLE 151. UNITED STATES BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2023 (USD MILLION)
• TABLE 152. UNITED STATES BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2024-2030 (USD MILLION)
• TABLE 153. UNITED STATES BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
• TABLE 154. UNITED STATES BIOREACTORS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
• TABLE 155. UNITED STATES BIOREACTORS MARKET SIZE, BY SCALE, 2018-2023 (USD MILLION)
• TABLE 156. UNITED STATES BIOREACTORS MARKET SIZE, BY SCALE, 2024-2030 (USD MILLION)
• TABLE 157. UNITED STATES BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
• TABLE 158. UNITED STATES BIOREACTORS MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
• TABLE 159. UNITED STATES BIOREACTORS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 160. UNITED STATES BIOREACTORS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 161. UNITED STATES BIOREACTORS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 162. UNITED STATES BIOREACTORS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 163. ASIA-PACIFIC BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2023 (USD MILLION)
• TABLE 164. ASIA-PACIFIC BIOREACTORS MARKET SIZE, BY MECHANISM, 2024-2030 (USD MILLION)
• TABLE 165. ASIA-PACIFIC BIOREACTORS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
• TABLE 166. ASIA-PACIFIC BIOREACTORS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
• TABLE 167. ASIA-PACIFIC BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2023 (USD MILLION)
• TABLE 168. ASIA-PACIFIC BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2024-2030 (USD MILLION)
• TABLE 169. ASIA-PACIFIC BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
• TABLE 170. ASIA-PACIFIC BIOREACTORS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
• TABLE 171. ASIA-PACIFIC BIOREACTORS MARKET SIZE, BY SCALE, 2018-2023 (USD MILLION)
• TABLE 172. ASIA-PACIFIC BIOREACTORS MARKET SIZE, BY SCALE, 2024-2030 (USD MILLION)
• TABLE 173. ASIA-PACIFIC BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
• TABLE 174. ASIA-PACIFIC BIOREACTORS MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
• TABLE 175. ASIA-PACIFIC BIOREACTORS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 176. ASIA-PACIFIC BIOREACTORS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 177. ASIA-PACIFIC BIOREACTORS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 178. ASIA-PACIFIC BIOREACTORS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 179. AUSTRALIA BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2023 (USD MILLION)
• TABLE 180. AUSTRALIA BIOREACTORS MARKET SIZE, BY MECHANISM, 2024-2030 (USD MILLION)
• TABLE 181. AUSTRALIA BIOREACTORS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
• TABLE 182. AUSTRALIA BIOREACTORS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
• TABLE 183. AUSTRALIA BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2023 (USD MILLION)
• TABLE 184. AUSTRALIA BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2024-2030 (USD MILLION)
• TABLE 185. AUSTRALIA BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
• TABLE 186. AUSTRALIA BIOREACTORS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
• TABLE 187. AUSTRALIA BIOREACTORS MARKET SIZE, BY SCALE, 2018-2023 (USD MILLION)
• TABLE 188. AUSTRALIA BIOREACTORS MARKET SIZE, BY SCALE, 2024-2030 (USD MILLION)
• TABLE 189. AUSTRALIA BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
• TABLE 190. AUSTRALIA BIOREACTORS MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
• TABLE 191. AUSTRALIA BIOREACTORS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 192. AUSTRALIA BIOREACTORS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 193. CHINA BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2023 (USD MILLION)
• TABLE 194. CHINA BIOREACTORS MARKET SIZE, BY MECHANISM, 2024-2030 (USD MILLION)
• TABLE 195. CHINA BIOREACTORS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
• TABLE 196. CHINA BIOREACTORS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
• TABLE 197. CHINA BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2023 (USD MILLION)
• TABLE 198. CHINA BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2024-2030 (USD MILLION)
• TABLE 199. CHINA BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
• TABLE 200. CHINA BIOREACTORS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
• TABLE 201. CHINA BIOREACTORS MARKET SIZE, BY SCALE, 2018-2023 (USD MILLION)
• TABLE 202. CHINA BIOREACTORS MARKET SIZE, BY SCALE, 2024-2030 (USD MILLION)
• TABLE 203. CHINA BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
• TABLE 204. CHINA BIOREACTORS MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
• TABLE 205. CHINA BIOREACTORS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 206. CHINA BIOREACTORS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 207. INDIA BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2023 (USD MILLION)
• TABLE 208. INDIA BIOREACTORS MARKET SIZE, BY MECHANISM, 2024-2030 (USD MILLION)
• TABLE 209. INDIA BIOREACTORS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
• TABLE 210. INDIA BIOREACTORS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
• TABLE 211. INDIA BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2023 (USD MILLION)
• TABLE 212. INDIA BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2024-2030 (USD MILLION)
• TABLE 213. INDIA BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
• TABLE 214. INDIA BIOREACTORS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
• TABLE 215. INDIA BIOREACTORS MARKET SIZE, BY SCALE, 2018-2023 (USD MILLION)
• TABLE 216. INDIA BIOREACTORS MARKET SIZE, BY SCALE, 2024-2030 (USD MILLION)
• TABLE 217. INDIA BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
• TABLE 218. INDIA BIOREACTORS MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
• TABLE 219. INDIA BIOREACTORS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 220. INDIA BIOREACTORS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 221. INDONESIA BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2023 (USD MILLION)
• TABLE 222. INDONESIA BIOREACTORS MARKET SIZE, BY MECHANISM, 2024-2030 (USD MILLION)
• TABLE 223. INDONESIA BIOREACTORS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
• TABLE 224. INDONESIA BIOREACTORS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
• TABLE 225. INDONESIA BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2023 (USD MILLION)
• TABLE 226. INDONESIA BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2024-2030 (USD MILLION)
• TABLE 227. INDONESIA BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
• TABLE 228. INDONESIA BIOREACTORS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
• TABLE 229. INDONESIA BIOREACTORS MARKET SIZE, BY SCALE, 2018-2023 (USD MILLION)
• TABLE 230. INDONESIA BIOREACTORS MARKET SIZE, BY SCALE, 2024-2030 (USD MILLION)
• TABLE 231. INDONESIA BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
• TABLE 232. INDONESIA BIOREACTORS MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
• TABLE 233. INDONESIA BIOREACTORS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 234. INDONESIA BIOREACTORS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 235. JAPAN BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2023 (USD MILLION)
• TABLE 236. JAPAN BIOREACTORS MARKET SIZE, BY MECHANISM, 2024-2030 (USD MILLION)
• TABLE 237. JAPAN BIOREACTORS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
• TABLE 238. JAPAN BIOREACTORS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
• TABLE 239. JAPAN BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2023 (USD MILLION)
• TABLE 240. JAPAN BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2024-2030 (USD MILLION)
• TABLE 241. JAPAN BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
• TABLE 242. JAPAN BIOREACTORS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
• TABLE 243. JAPAN BIOREACTORS MARKET SIZE, BY SCALE, 2018-2023 (USD MILLION)
• TABLE 244. JAPAN BIOREACTORS MARKET SIZE, BY SCALE, 2024-2030 (USD MILLION)
• TABLE 245. JAPAN BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
• TABLE 246. JAPAN BIOREACTORS MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
• TABLE 247. JAPAN BIOREACTORS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 248. JAPAN BIOREACTORS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 249. MALAYSIA BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2023 (USD MILLION)
• TABLE 250. MALAYSIA BIOREACTORS MARKET SIZE, BY MECHANISM, 2024-2030 (USD MILLION)
• TABLE 251. MALAYSIA BIOREACTORS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
• TABLE 252. MALAYSIA BIOREACTORS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
• TABLE 253. MALAYSIA BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2023 (USD MILLION)
• TABLE 254. MALAYSIA BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2024-2030 (USD MILLION)
• TABLE 255. MALAYSIA BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
• TABLE 256. MALAYSIA BIOREACTORS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
• TABLE 257. MALAYSIA BIOREACTORS MARKET SIZE, BY SCALE, 2018-2023 (USD MILLION)
• TABLE 258. MALAYSIA BIOREACTORS MARKET SIZE, BY SCALE, 2024-2030 (USD MILLION)
• TABLE 259. MALAYSIA BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
• TABLE 260. MALAYSIA BIOREACTORS MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
• TABLE 261. MALAYSIA BIOREACTORS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 262. MALAYSIA BIOREACTORS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 263. PHILIPPINES BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2023 (USD MILLION)
• TABLE 264. PHILIPPINES BIOREACTORS MARKET SIZE, BY MECHANISM, 2024-2030 (USD MILLION)
• TABLE 265. PHILIPPINES BIOREACTORS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
• TABLE 266. PHILIPPINES BIOREACTORS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
• TABLE 267. PHILIPPINES BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2023 (USD MILLION)
• TABLE 268. PHILIPPINES BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2024-2030 (USD MILLION)
• TABLE 269. PHILIPPINES BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
• TABLE 270. PHILIPPINES BIOREACTORS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
• TABLE 271. PHILIPPINES BIOREACTORS MARKET SIZE, BY SCALE, 2018-2023 (USD MILLION)
• TABLE 272. PHILIPPINES BIOREACTORS MARKET SIZE, BY SCALE, 2024-2030 (USD MILLION)
• TABLE 273. PHILIPPINES BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
• TABLE 274. PHILIPPINES BIOREACTORS MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
• TABLE 275. PHILIPPINES BIOREACTORS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 276. PHILIPPINES BIOREACTORS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 277. SINGAPORE BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2023 (USD MILLION)
• TABLE 278. SINGAPORE BIOREACTORS MARKET SIZE, BY MECHANISM, 2024-2030 (USD MILLION)
• TABLE 279. SINGAPORE BIOREACTORS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
• TABLE 280. SINGAPORE BIOREACTORS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
• TABLE 281. SINGAPORE BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2023 (USD MILLION)
• TABLE 282. SINGAPORE BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2024-2030 (USD MILLION)
• TABLE 283. SINGAPORE BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
• TABLE 284. SINGAPORE BIOREACTORS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
• TABLE 285. SINGAPORE BIOREACTORS MARKET SIZE, BY SCALE, 2018-2023 (USD MILLION)
• TABLE 286. SINGAPORE BIOREACTORS MARKET SIZE, BY SCALE, 2024-2030 (USD MILLION)
• TABLE 287. SINGAPORE BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
• TABLE 288. SINGAPORE BIOREACTORS MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
• TABLE 289. SINGAPORE BIOREACTORS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 290. SINGAPORE BIOREACTORS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 291. SOUTH KOREA BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2023 (USD MILLION)
• TABLE 292. SOUTH KOREA BIOREACTORS MARKET SIZE, BY MECHANISM, 2024-2030 (USD MILLION)
• TABLE 293. SOUTH KOREA BIOREACTORS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
• TABLE 294. SOUTH KOREA BIOREACTORS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
• TABLE 295. SOUTH KOREA BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2023 (USD MILLION)
• TABLE 296. SOUTH KOREA BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2024-2030 (USD MILLION)
• TABLE 297. SOUTH KOREA BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
• TABLE 298. SOUTH KOREA BIOREACTORS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
• TABLE 299. SOUTH KOREA BIOREACTORS MARKET SIZE, BY SCALE, 2018-2023 (USD MILLION)
• TABLE 300. SOUTH KOREA BIOREACTORS MARKET SIZE, BY SCALE, 2024-2030 (USD MILLION)
• TABLE 301. SOUTH KOREA BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
• TABLE 302. SOUTH KOREA BIOREACTORS MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
• TABLE 303. SOUTH KOREA BIOREACTORS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 304. SOUTH KOREA BIOREACTORS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 305. TAIWAN BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2023 (USD MILLION)
• TABLE 306. TAIWAN BIOREACTORS MARKET SIZE, BY MECHANISM, 2024-2030 (USD MILLION)
• TABLE 307. TAIWAN BIOREACTORS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
• TABLE 308. TAIWAN BIOREACTORS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
• TABLE 309. TAIWAN BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2023 (USD MILLION)
• TABLE 310. TAIWAN BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2024-2030 (USD MILLION)
• TABLE 311. TAIWAN BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
• TABLE 312. TAIWAN BIOREACTORS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
• TABLE 313. TAIWAN BIOREACTORS MARKET SIZE, BY SCALE, 2018-2023 (USD MILLION)
• TABLE 314. TAIWAN BIOREACTORS MARKET SIZE, BY SCALE, 2024-2030 (USD MILLION)
• TABLE 315. TAIWAN BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
• TABLE 316. TAIWAN BIOREACTORS MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
• TABLE 317. TAIWAN BIOREACTORS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 318. TAIWAN BIOREACTORS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 319. THAILAND BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2023 (USD MILLION)
• TABLE 320. THAILAND BIOREACTORS MARKET SIZE, BY MECHANISM, 2024-2030 (USD MILLION)
• TABLE 321. THAILAND BIOREACTORS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
• TABLE 322. THAILAND BIOREACTORS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
• TABLE 323. THAILAND BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2023 (USD MILLION)
• TABLE 324. THAILAND BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2024-2030 (USD MILLION)
• TABLE 325. THAILAND BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
• TABLE 326. THAILAND BIOREACTORS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
• TABLE 327. THAILAND BIOREACTORS MARKET SIZE, BY SCALE, 2018-2023 (USD MILLION)
• TABLE 328. THAILAND BIOREACTORS MARKET SIZE, BY SCALE, 2024-2030 (USD MILLION)
• TABLE 329. THAILAND BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
• TABLE 330. THAILAND BIOREACTORS MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
• TABLE 331. THAILAND BIOREACTORS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 332. THAILAND BIOREACTORS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 333. VIETNAM BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2023 (USD MILLION)
• TABLE 334. VIETNAM BIOREACTORS MARKET SIZE, BY MECHANISM, 2024-2030 (USD MILLION)
• TABLE 335. VIETNAM BIOREACTORS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
• TABLE 336. VIETNAM BIOREACTORS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
• TABLE 337. VIETNAM BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2023 (USD MILLION)
• TABLE 338. VIETNAM BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2024-2030 (USD MILLION)
• TABLE 339. VIETNAM BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
• TABLE 340. VIETNAM BIOREACTORS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
• TABLE 341. VIETNAM BIOREACTORS MARKET SIZE, BY SCALE, 2018-2023 (USD MILLION)
• TABLE 342. VIETNAM BIOREACTORS MARKET SIZE, BY SCALE, 2024-2030 (USD MILLION)
• TABLE 343. VIETNAM BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
• TABLE 344. VIETNAM BIOREACTORS MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
• TABLE 345. VIETNAM BIOREACTORS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 346. VIETNAM BIOREACTORS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 347. EUROPE, MIDDLE EAST & AFRICA BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2023 (USD MILLION)
• TABLE 348. EUROPE, MIDDLE EAST & AFRICA BIOREACTORS MARKET SIZE, BY MECHANISM, 2024-2030 (USD MILLION)
• TABLE 349. EUROPE, MIDDLE EAST & AFRICA BIOREACTORS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
• TABLE 350. EUROPE, MIDDLE EAST & AFRICA BIOREACTORS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
• TABLE 351. EUROPE, MIDDLE EAST & AFRICA BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2023 (USD MILLION)
• TABLE 352. EUROPE, MIDDLE EAST & AFRICA BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2024-2030 (USD MILLION)
• TABLE 353. EUROPE, MIDDLE EAST & AFRICA BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
• TABLE 354. EUROPE, MIDDLE EAST & AFRICA BIOREACTORS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
• TABLE 355. EUROPE, MIDDLE EAST & AFRICA BIOREACTORS MARKET SIZE, BY SCALE, 2018-2023 (USD MILLION)
• TABLE 356. EUROPE, MIDDLE EAST & AFRICA BIOREACTORS MARKET SIZE, BY SCALE, 2024-2030 (USD MILLION)
• TABLE 357. EUROPE, MIDDLE EAST & AFRICA BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
• TABLE 358. EUROPE, MIDDLE EAST & AFRICA BIOREACTORS MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
• TABLE 359. EUROPE, MIDDLE EAST & AFRICA BIOREACTORS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 360. EUROPE, MIDDLE EAST & AFRICA BIOREACTORS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 361. EUROPE, MIDDLE EAST & AFRICA BIOREACTORS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 362. EUROPE, MIDDLE EAST & AFRICA BIOREACTORS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 363. DENMARK BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2023 (USD MILLION)
• TABLE 364. DENMARK BIOREACTORS MARKET SIZE, BY MECHANISM, 2024-2030 (USD MILLION)
• TABLE 365. DENMARK BIOREACTORS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
• TABLE 366. DENMARK BIOREACTORS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
• TABLE 367. DENMARK BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2023 (USD MILLION)
• TABLE 368. DENMARK BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2024-2030 (USD MILLION)
• TABLE 369. DENMARK BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
• TABLE 370. DENMARK BIOREACTORS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
• TABLE 371. DENMARK BIOREACTORS MARKET SIZE, BY SCALE, 2018-2023 (USD MILLION)
• TABLE 372. DENMARK BIOREACTORS MARKET SIZE, BY SCALE, 2024-2030 (USD MILLION)
• TABLE 373. DENMARK BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
• TABLE 374. DENMARK BIOREACTORS MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
• TABLE 375. DENMARK BIOREACTORS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 376. DENMARK BIOREACTORS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 377. EGYPT BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2023 (USD MILLION)
• TABLE 378. EGYPT BIOREACTORS MARKET SIZE, BY MECHANISM, 2024-2030 (USD MILLION)
• TABLE 379. EGYPT BIOREACTORS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
• TABLE 380. EGYPT BIOREACTORS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
• TABLE 381. EGYPT BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2023 (USD MILLION)
• TABLE 382. EGYPT BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2024-2030 (USD MILLION)
• TABLE 383. EGYPT BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2023 (USD MILLION)
• TABLE 384. EGYPT BIOREACTORS MARKET SIZE, BY MATERIAL, 2024-2030 (USD MILLION)
• TABLE 385. EGYPT BIOREACTORS MARKET SIZE, BY SCALE

[186 Pages Report] The Bioreactors Market size was estimated at USD 3.26 billion in 2023 and expected to reach USD 3.57 billion in 2024, at a CAGR 9.46% to reach USD 6.15 billion by 2030.

The bioreactor involves designing, producing, using, and maintaining specialized vessels that provide controlled environments for biological processes in various industries such as pharmaceuticals, food & beverage, biotechnology research facilities, and wastewater treatment plants. Increasing demand for personalized medicines and therapeutic antibodies, technological advancements in functional capabilities, and rising investments from government agencies and private sectors to expand the manufacturing of vaccines is driving the market growth. The rising usage of single-use bioreactors across pharmaceutical and waste treatment facilities is expanding the scope of the market. However, certain safety and maintenance issues with high usage of bioreactors are expected to hamper the market growth. Increasing research and development activities to introduce advanced bioreactors that enable biopharmaceutical businesses to improve the efficiency and precision of their operations is expected to create opportunities for market growth. The ongoing advancements in bioreactors are expected to develop standardized, repeatable cell-based products for regenerative medical applications and establish physiologically realistic in vitro models for drug testing.

Mechanism: Adoption of photo-bioreactors for the growth of photosynthetic microorganisms

Airlift bioreactors are ideal for low-shear stress processes and high oxygen transfer applications, including aerobic fermentation and cell culture. Benchtop bioreactors, designed for small-scale experiments and process development, are popular in laboratories and research institutions. Bubble column bioreactors utilize gas sparging for mixing and mass transfer, making them suitable for large-scale production due to their simple design and low operating costs. Continuous Stirred Tank Bioreactors (CSTR) offer flexible process control for homogenous liquid-phase reactions. Fluidized bed bioreactors excel in high-density cell culture processes where immobilized cells or microorganisms are suspended in a liquid medium. Microbial bioreactors cater specifically to microorganism cultivation for protein production, enzyme synthesis, and waste treatment applications. Multi-parallel bioreactors allow simultaneous experiments with multiple reactors under controlled conditions. These reactors are favored for process optimization, high-throughput screening, and scale-up studies. Packed bed bioreactors contain immobilized cells or particles within a porous matrix, providing high cell density cultivation and large surface areas for cell attachment. These reactors are utilized in applications such as biofilm-based processes and wastewater treatment. Photo-bioreactors supply controlled light conditions vital for the growth of photosynthetic microorganisms, ensuring optimal cultivation environments.

Usage: Preferences for full-scale production from various industries due to large volume processing capacity

Full-scale production represents the highest level of bioreactor usage type regarding volume capacity and operational complexity. These large-capacity systems range from 1,000 to over 20,000 liters and are utilized in various industries, such as pharmaceuticals, biotechnology, food processing, agriculture, and environmental management. In full-scale bioreactors, large quantities of cells and microorganisms are cultivated under controlled conditions to produce desired products, such as recombinant proteins and enzymes, for various applications. The primary focus in this segment is high-yield productivity while maintaining product quality and consistency with efficient resource utilization. Lab-scale production refers to small-sized bioreactors used primarily for research at academic institutions or industrial R&D centers with a working volume ranging from 1 liter to 10 liters. Their compact size allows for easy handling and operation within laboratory environments while providing essential features similar to larger-scale systems, such as pH control and temperature regulation. Researchers can perform various experimental procedures in lab-scale production settings, including cell culture optimization studies or media screening tests on a smaller scale before transitioning processes to larger pilot- or full-scale systems, saving time and resources. Pilot-scale production is an intermediate stage between lab- and full-scale productions where processes developed at benchtop scale are scaled up to accommodate larger working volumes of around 100 to a few thousand liters. This stage is crucial for evaluating and optimizing bioprocess parameters since it bridges the gap between small-scale lab studies and commercial-scale manufacturing. In pilot-scale bioreactors, various factors such as mass transfer rates, mixing patterns, and nutrient supply can be studied under more realistic conditions, providing valuable data on process robustness, scalability, and economic feasibility. Pilot facilities also serve as an essential platform for process validation, technology transfer activities, and regulatory compliance testing.

Control Type: Adoption of automated bioreactors due to high level of precision and consistency in process control

Automated bioreactors are advanced systems that control and monitor critical process parameters, such as pH, temperature, dissolved oxygen, and agitation speed. These bioreactors offer high precision and consistency in process control, resulting in improved product quality and reduced batch variability. Automated bioreactors are preferred in large-scale industrial production processes where continuous monitoring and precise control are essential for optimal performance. Manual bioreactors require operators to adjust process parameters during cell cultivation or fermentation processes manually. These systems provide users with greater flexibility to alter conditions based on specific requirements and are used in smaller-scale research laboratories where frequent adjustments may be required for optimizing experimental conditions.

Material : Increasing usage of stainless steel bioreactors in the pharmaceutical and biotech industries owing to their durability and scalability

Bioreactors are integral components in bioprocess applications, commonly made of glass or stainless steel. Glass bioreactors offer transparency and chemical resistance, allowing for observing culture growth, cell morphology, and processes up to 15 L in volume. On the other hand, stainless steel bioreactors excel in durability and scalability, making them ideal for large-scale manufacturing processes ranging from 20L to 1000L or more, particularly in the pharmaceutical and biotech industries. Each type of bioreactor has distinct advantages depending on specific application requirements. It is recommended that end-users consult with manufacturers/providers to determine the most suitable model for their needs.

Scale: Suitability of 200L-1500L bioreactors for pilot-scale and small-scale commercial manufacturing processes

The 1500L-4000L scale caters to large-scale production facilities that require high throughput and increased output for commercial manufacturing. It is preferred for producing monoclonal antibodies, vaccines, and recombinant proteins. 200L-1500L bioreactors are suitable for pilot-scale and small-scale commercial manufacturing processes that offer efficient scaling-up capabilities from benchtop systems. These bioreactors are commonly used for cell culture processes involving mammalian or microbial cells. The 20L-200L bioreactors serve the needs of process development and optimization at the laboratory and pilot scale. This range provides effective scaling-down capabilities, enabling optimal process conditions for larger-scale systems. The 5L-20L bioreactor is well-suited for research and development applications, initial screening studies, and media optimization. Benchtop bioreactors with working volumes from 5L to 20L offer flexibility in terms of easy handling and reduced space requirements. The above 4000L scale bioreactors cater to large-scale commercial manufacturing operations that require high-capacity production facilities for extensive output demands. These systems are commonly employed for producing biotherapeutics on a massive scale and large-volume fermentation processes.

Usability: Preferences for single-use bioreactors due to their flexibility, & reduced risk of cross-contamination

Reusable bioreactors are constructed from durable materials such as stainless steel and glass and are used multiple times after proper cleaning and sterilization. They are widely employed in large-scale manufacturing processes due to their ability to handle high cell densities and larger volumes. Single-use bioreactors employ disposable components made from materials, including plastics and polymers, disposed of after each use. These systems have become widespread due to their flexibility, reduced risk of cross-contamination, and faster turnaround times for production runs.

End User: Increasing applicability in biopharmaceutical industry, for producing biotherapeutics including monoclonal antibodies & vaccines

Bioreactors play a crucial role in the biopharmaceutical industry, producing biotherapeutics such as monoclonal antibodies, vaccines, recombinant proteins, and cell therapy products. These companies rely on bioreactors to provide optimal conditions for cell growth and protein expression while maintaining sterility throughout biomanufacturing. The ability to scale production from laboratory to large-scale commercial manufacturing makes bioreactors indispensable in biopharmaceutical. CMOs and CROs offer specialized services related to drug development and manufacturing on a contractual basis. CMOs and CROs utilize bioreactors for various applications such as process development, optimization studies, scale-up activities, clinical trial material production, and commercial manufacturing of therapeutic products. Bioreactors are also employed in waste management industries such as landfills and waste treatment plants for anaerobic digestion and biogas production processes. These systems utilize microorganisms to break down organic matter, generate energy from methane gas, and reduce greenhouse gas emissions. The efficient design and operation of bioreactors play a pivotal role in determining the overall effectiveness of these processes. Research laboratories and academic institutions rely on bioreactors for various research activities involving cell culture studies, fermentation processes, biochemical engineering investigations, and developing new bio-based products and alternative energy sources. Bioreactors offer a controlled environment to study cellular responses under different growth conditions, such as pH levels or nutrient availability, enabling researchers to optimize process parameters or investigate novel biological pathways.

Regional Insights

In the Americas region, specifically in North America, the demand for single-use or disposable bioreactors is increasing due to their ability to reduce cross-contamination risks. The highly developed life sciences industry and robust funding from both public and private sectors are creating a platform for the growth of the bioreactors market in the Americas. Increasing expansion of pharmaceutical manufacturing capabilities, and rapid industrialization are leading to greater production capacity requirements for vaccines, biosimilars, and stem cell therapies, subsequently, rising utilization of bioreactors in the Asia-Pacific. Moreover, government initiatives promoting R&D investments coupled with favorable regulatory policies are expected to benefit the market growth in the Asia-Pacific. In the EMEA, Europe occupies a dominant position within the global bioreactor market with nations such as Germany, France, and UK leading regional growth. This can be attributed to factors such as well-established pharmaceutical companies with robust product pipelines, supportive government policies, increasing collaborations between academic institutions and market players, and a strong emphasis on bioprocess innovation. On the other hand, the Middle East and Africa are gradually embracing bioreactors as countries such as Saudi Arabia and South Africa continue to invest in biopharma infrastructure development and capacity expansion.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Bioreactors Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Bioreactors Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Bioreactors Market, highlighting leading vendors and their innovative profiles. These include 3D Biotek LLC, ABEC, Inc., Adolf Kuhner AG, BBI-biotech GmbH, Belach Bioteknik, Bioengineering AG, Bionet Servicios Tecnicos, SL, Broadley-James Corporation, Cell Culture Company, LLC, Cellexus Limited, CerCell A/S, Cesco Bioengineering Co., Ltd., Danaher Corporation, Distek, Inc., Electrolab Biotech Limited, Eppendorf SE, FiberCell Systems Inc., G&G Technologies, Inc., GEA Group AG, Getinge AB, IKA-Werke GmbH & CO. KG, Infors AG, Lonza Group Ltd., Merck KGaA, PBS Biotech, Inc., Pierre Guerin SA, Praj Industries Limited, Sartorius AG, Shanghai LePure Biotech Co., Ltd., Solaris Biotechnolgy Srl by Donaldson Company, Inc., Solida Biotech GmBH, Terumo Corporation, Thermo Fisher Scientific Inc., WuXi Biologics (Cayman) Inc., and ZETA GmbH.

Market Segmentation & Coverage

This research report categorizes the Bioreactors Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Mechanism
  • Airlift Bioreactors
  • Benchtop Bioreactors
  • Bubble Column Bioreactors
  • Continuous Stirred Tank Bioreactors
  • Fluidized Bed Bioreactors
  • Microbial Bioreactors
  • Multi-Parallel Bioreactors
  • Packed Bed Bioreactors
  • Photo-Bioreactors

• Usage
  • Full-scale Production
  • Lab-Scale Production
  • Pilot-scale Production

• Control Type
  • Automated
  • Manual

• Material
  • Glass
  • Stainless Steel

• Scale
  • 1500L-4000L
  • 200L-1500L
  • 20L-200L
  • 5L-20L
  • Above 4000L

• Usability
  • Reusable
  • Single-use

• End User
  • Biopharmaceutical Companies & Manufacturers
  • Contract Manufacturing Organizations & Contract Research Organizations
  • Landfills & Waste Treatment Plants
  • R&D Departments & Institutes

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Bioreactors Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Bioreactors Market?

3. What are the technology trends and regulatory frameworks in the Bioreactors Market?

4. What is the market share of the leading vendors in the Bioreactors Market?

5. Which modes and strategic moves are suitable for entering the Bioreactors Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rapid growth of biopharmaceuticals and biologics industries
    • 5.1.1.2. Adoption of single-use bioreactors (subs) and hybrid bioreactors
  • 5.1.2. Restraints
    • 5.1.2.1. Maintenance issues and high power consumption issues with bioreactors
  • 5.1.3. Opportunities
    • 5.1.3.1. Continuous technological advancements in the development of novel bioreactors
    • 5.1.3.2. High potential of bioreactors in the wastewater treatment process
  • 5.1.4. Challenges
    • 5.1.4.1. Safety and environmental concerns associated with the use of bioreactors
• 5.2. Market Segmentation Analysis
  • 5.2.1. Mechanism: Adoption of photo-bioreactors for the growth of photosynthetic microorganisms
  • 5.2.2. Usage: Preferences for full-scale production from various industries due to large volume processing capacity
  • 5.2.3. Control Type: Adoption of automated bioreactors due to high level of precision and consistency in process control
  • 5.2.4. Material : Increasing usage of stainless steel bioreactors in the pharmaceutical and biotech industries owing to their durability and scalability
  • 5.2.5. Scale: Suitability of 200L-1500L bioreactors for pilot-scale and small-scale commercial manufacturing processes
  • 5.2.6. Usability: Preferences for single-use bioreactors due to their flexibility, & reduced risk of cross-contamination
  • 5.2.7. End User: Increasing applicability in biopharmaceutical industry, for producing biotherapeutics including monoclonal antibodies & vaccines
• 5.3. Market Trend Analysis
  • 5.3.1. Emphasis on R&D activities for advanced bioreactors with the support of established production facilities in the Americas
  • 5.3.2. Supportive government initiatives and enhanced technology adoption in drug manufacturing
  • 5.3.3. Vigorous biopharmaceutical research activities and well-established players in the region
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework Analysis

6. Bioreactors Market, by Mechanism

• 6.1. Introduction
• 6.2. Airlift Bioreactors
• 6.3. Benchtop Bioreactors
• 6.4. Bubble Column Bioreactors
• 6.5. Continuous Stirred Tank Bioreactors
• 6.6. Fluidized Bed Bioreactors
• 6.7. Microbial Bioreactors
• 6.8. Multi-Parallel Bioreactors
• 6.9. Packed Bed Bioreactors
• 6.10. Photo-Bioreactors

7. Bioreactors Market, by Usage

• 7.1. Introduction
• 7.2. Full-scale Production
• 7.3. Lab-Scale Production
• 7.4. Pilot-scale Production

8. Bioreactors Market, by Control Type

• 8.1. Introduction
• 8.2. Automated
• 8.3. Manual

9. Bioreactors Market, by Material

• 9.1. Introduction
• 9.2. Glass
• 9.3. Stainless Steel

10. Bioreactors Market, by Scale

• 10.1. Introduction
• 10.2. 1500L-4000L
• 10.3. 200L-1500L
• 10.4. 20L-200L
• 10.5. 5L-20L
• 10.6. Above 4000L

11. Bioreactors Market, by Usability

• 11.1. Introduction
• 11.2. Reusable
• 11.3. Single-use

12. Bioreactors Market, by End User

• 12.1. Introduction
• 12.2. Biopharmaceutical Companies & Manufacturers
• 12.3. Contract Manufacturing Organizations & Contract Research Organizations
• 12.4. Landfills & Waste Treatment Plants
• 12.5. R&D Departments & Institutes

13. Americas Bioreactors Market

• 13.1. Introduction
• 13.2. Argentina
• 13.3. Brazil
• 13.4. Canada
• 13.5. Mexico
• 13.6. United States

14. Asia-Pacific Bioreactors Market

• 14.1. Introduction
• 14.2. Australia
• 14.3. China
• 14.4. India
• 14.5. Indonesia
• 14.6. Japan
• 14.7. Malaysia
• 14.8. Philippines
• 14.9. Singapore
• 14.10. South Korea
• 14.11. Taiwan
• 14.12. Thailand
• 14.13. Vietnam

15. Europe, Middle East & Africa Bioreactors Market

• 15.1. Introduction
• 15.2. Denmark
• 15.3. Egypt
• 15.4. Finland
• 15.5. France
• 15.6. Germany
• 15.7. Israel
• 15.8. Italy
• 15.9. Netherlands
• 15.10. Nigeria
• 15.11. Norway
• 15.12. Poland
• 15.13. Qatar
• 15.14. Russia
• 15.15. Saudi Arabia
• 15.16. South Africa
• 15.17. Spain
• 15.18. Sweden
• 15.19. Switzerland
• 15.20. Turkey
• 15.21. United Arab Emirates
• 15.22. United Kingdom

16. Competitive Landscape

• 16.1. Market Share Analysis, 2023
• 16.2. FPNV Positioning Matrix, 2023
• 16.3. Competitive Scenario Analysis
  • 16.3.1. Sartorius Bioreactors Integrate Emerson Technology to Speed New Therapies to Market
  • 16.3.2. Merger of Cytiva and Pall's Life Sciences Business Now Complete
  • 16.3.3. PBS Biotech and denovoMATRIX Join Forces to Boost Manufacturing Processes for Cell & Gene Therapies
  • 16.3.4. Lonza and Adva Biotechnology Ltd. Agree to Expand Availability and Use of Automated Bioreactors with License to Lonza's Patents
  • 16.3.5. Novo Holdings co-leads Series C financing in LePure Biotech
  • 16.3.6. PBS Biotech Raises USD 22 million to Expand Single-Use Manufacturing Products and Services for Cell Therapy Clients
  • 16.3.7. Merck Gains Leading Perfusion Micro-Bioreactor with Erbi Biosystems Acquisition
  • 16.3.8. Solaris Biotech and Wildtype Announce Agreement for Large-scale Bioreactors for Cultivated Seafood Production
  • 16.3.9. STEMCELL Technologies and PBS Biotech Partner to Enable Robust Scale Up of Human Pluripotent Stem Cell 3D Cultures
  • 16.3.10. Stamm Biotech Raises USD 17 Million To Develop Desktop 3D Printed Bioreactor

17. Competitive Portfolio

• 17.1. Key Company Profiles
• 17.2. Key Product Portfolio